AzTrials
AzTrials

Tomography, Optical CoherenceNCT06341361

OCT-based Machine Learning FFR for Predicting Post-PCI FFR

An observational study of Tomography, Optical Coherence and Fractional Flow Reserve, Myocardial, run by Yonsei University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to compare the diagnostic accuracy of the fractional flow reserve (FFR) model derived by machine learning based on optical coherence tomography (OCT) exam after coronary artery stent implantation with the wire-based FFR. Read more about this study

Who is it for?
Ages 19 years and older
What is being tested?
OCT-based machine learning FFR
How many people
82 participants
Where
No sites listed yet
Study dates
15 Apr 2024to 15 Oct 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Among patients who underwent PCI for ischemic heart disease, those who underwent both OCT examination and pressure wire-based FFR after coronary artery stenting.

Who may be able to join

  • Patients who underwent stent implantation for ischemic heart disease
  • Patients who underwent both OCT examination and FFR using a pressure wire after PCI

Who cannot join

  • Poor OCT imaging quality
  • Patients with severe left ventricular dysfunction (<30%)
  • Patients with severe valvular heart disease
  • Patients with a life expectancy of less than 1 year

Trial locations and contacts

No sites are listed yet.

Oh-Hyun Lee, MD contact

+82-31-5189-8786

Decenthyun@yuhs.ac

About this study

Official title: Optical Coherence Tomography-based Machine Learning for Predicting Fractional Flow Reserve After Coronary Artery Stenting

This study aims to compare the diagnostic accuracy of the fractional flow reserve (FFR) model derived by machine learning based on optical coherence tomography (OCT) exam after coronary artery stent implantation with the wire-based FFR.

Read the detailed description

FFR and OCT exam are used for different purposes during percutaneous coronary intervention (PCI). The FFR is a decision-making tool to determine if additional procedures are necessary, while the OCT exam is used to optimize the stent procedure. The use of both tests provides additional information to help perform a excellent procedure, but it is more expensive and time-consuming.

Therefore, an OCT-derived machine learning FFR test may be helpful. Previous studies have demonstrated that OCT-based machine learning FFR before the procedure has shown good diagnostic performance in predicting FFR, irrespective of the coronary territory.

Despite the rapid development of technologies and tools for PCI, a significant number of patients experienced adverse events, such as recurrence of angina and silent ischemia despite angiographically successful PCI. Suboptimal PCI is a well-known independent prognostic factor for major cardiovascular accidents. Therefore, measuring post-PCI FFR immediately after stent implantation is crucial to optimize the procedure outcome and improve the patient's prognosis. Although the importance of measuring post-PCI FFR is gradually emerging, there is currently no model for OCT-based machine learning FFR that predicts FFR after stent insertion. In patients who underwent percutaneous coronary intervention using stents for ischemic heart disease, we will compare the diagnostic accuracy of the fractional flow reserve (FFR) model derived by machine learning based on optical coherence tomography (OCT) exam after coronary artery stent implantation with the wire-based FFR.

Being tested
OCT-based machine learning FFR

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • OCT-based machine learning FFRDiagnostic test

    OCT-based machine learning FFR and wire-based FFR

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correlation of OCT-based machine learning FFR compared to wire-based FFR

    Determining the diagnostic accuracy of CT-FFR values obtained by the new method compared with invasive coronary angiography with fractional flow reserve

    Measured: 4 weeks

Secondary outcomes (2)
  1. Diagnostic performance of OCT-based machine learning FFR compared to wire-based FFR

    Accuracy, sensitivity, specificity, positive predictive value, negative predictive value

    Measured: 4 weeks

  2. Diagnostic performance of OCT-based machine learning FFR according to the coronary artery (LAD, LCx or RCA) compared to wire-based FFR

    Accuracy, sensitivity, specificity, positive predictive value, negative predictive value

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2024
  2. Study start15 Apr 2024 (estimated)
  3. Primary completion30 Apr 2024 (estimated)
  4. Study completion15 Oct 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
82 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06341361
Sponsor's protocol ID
OCT-FFR
Status last verified
Mar 2024
First submitted
26 Mar 2024
Last updated
2 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Tomography, Optical Coherence and Fractional Flow Reserve, Myocardial, run by Yonsei University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Oh-Hyun Lee, MD (+82-31-5189-8786, Decenthyun@yuhs.ac), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correlation of OCT-based machine learning FFR compared to wire-based FFR (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in